Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world’s most dangerous infectious diseases - tuberculosis, malaria and dengue virus — in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders. The Institute received four project awards totaling $18.8 million from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to fund the study…

Read the rest here:
Institute To Identify New Vaccine Targets For Tuberculosis, Malaria, Dengue Virus And Smallpox

You may also like:

• Research On Leishmaniasis In Ethiopia Benefits From $5 Million Grant To Hebrew U.
• 6 PNNL Scientists Elected AAAS Fellows
• Chronic Lyme Disease, How Often Is It Diagnosed And Treated?
• Biosynthetic Corneas Restore Vision In Humans
• Artepharm Global Corp.: World Health Organisation Reports Half The Worlds Population Is At Risk Of Malaria
• New Edition Of Infectious Diseases Announced By Elsevier
• Developed At The University Of Washington, Neuroscience Website Is Designed To Capture The Interest Of Students Of All Ages
• NIH Committee Recommends Withholding Federal Support For 47 Stem Cell Lines
• Genetic Differences Between Neandertals And Modern Humans Revealed By Neandertal Genome Sequence
• News Outlets Examine World Malaria Day 2010